首页 > 最新文献

Anaesthesia, Pain & Intensive Care最新文献

英文 中文
Ultrasound guided erector spinae plane catheter for thoracotomy: a case report 超声引导竖脊平面导管开胸术1例
IF 0.2 Q4 Medicine Pub Date : 2021-12-12 DOI: 10.35975/apic.v25i6.1707
A. Usman, A. Khan, M. Ijaz
Major thoracic surgery results in severe postoperative pain. Epidural analgesia is considered the gold standard for pain management after thoracic surgery. However, epidural blocks are contraindicated in certain clinical conditions. Pain management in such patients poses a unique challenge to the anesthesiologists. Erector spinae plane block (ESPB) is a less invasive and relatively new technique, which has shown promising results. This case report describes the use of ESPB as an alternate analgesic technique. A 65-year-old man underwent thoracotomy and left upper lobe resection. Intraoperative and postoperative pain was managed with intermittent boluses of bupivacaine through the erector spinae plane catheter. Effective analgesia was achieved with minimal morphine consumption in postoperative period. Although central neuraxial blocks are considered to be gold standard for major thoracic surgery but where applicable, alternatives can be opted for better patient outcomes. Key words: Analgesia; Erector spinae plane block; Thoracotomy; Pain control; Neuraxial analgesia Citation: Usman A, Khan AW, Ijaz MK. Ultrasound guided erector spinae plane catheter for thoracotomy: a case report. Anaesth. pain intensive care 2021;25(6):812–815; DOI: 10.35975/apic.v25i6.1707 Received: August 16, 2021, Reviewed: October 28, 2021, Accepted: October 31, 2021
大的胸外科手术导致严重的术后疼痛。硬膜外镇痛被认为是胸外科手术后疼痛管理的金标准。然而,硬膜外阻滞在某些临床条件下是禁忌的。此类患者的疼痛管理对麻醉师提出了独特的挑战。直立脊柱平面阻滞(ESPB)是一种创伤小且相对较新的技术,已显示出良好的效果。本病例报告描述了ESPB作为一种替代镇痛技术的使用。一位65岁的男性接受了开胸和左上肺叶切除术。术中和术后疼痛通过竖脊平面导管间歇大剂量布比卡因治疗。术后吗啡用量少,镇痛效果好。虽然中枢神经轴阻滞被认为是大胸外科手术的金标准,但在适用的情况下,可以选择其他方法以获得更好的患者预后。关键词:镇痛;竖脊面块;开胸;疼痛控制;引用本文:Usman A, Khan AW, Ijaz MK.超声引导直立脊柱平面导管用于开胸术1例。Anaesth。疼痛重症监护2021;25(6):812-815;收稿日期:2021年8月16日,审稿日期:2021年10月28日,接收日期:2021年10月31日
{"title":"Ultrasound guided erector spinae plane catheter for thoracotomy: a case report","authors":"A. Usman, A. Khan, M. Ijaz","doi":"10.35975/apic.v25i6.1707","DOIUrl":"https://doi.org/10.35975/apic.v25i6.1707","url":null,"abstract":"Major thoracic surgery results in severe postoperative pain. Epidural analgesia is considered the gold standard for pain management after thoracic surgery. However, epidural blocks are contraindicated in certain clinical conditions. Pain management in such patients poses a unique challenge to the anesthesiologists. Erector spinae plane block (ESPB) is a less invasive and relatively new technique, which has shown promising results. This case report describes the use of ESPB as an alternate analgesic technique. A 65-year-old man underwent thoracotomy and left upper lobe resection. Intraoperative and postoperative pain was managed with intermittent boluses of bupivacaine through the erector spinae plane catheter. Effective analgesia was achieved with minimal morphine consumption in postoperative period. Although central neuraxial blocks are considered to be gold standard for major thoracic surgery but where applicable, alternatives can be opted for better patient outcomes. \u0000Key words: Analgesia; Erector spinae plane block; Thoracotomy; Pain control; Neuraxial analgesia \u0000Citation: Usman A, Khan AW, Ijaz MK. Ultrasound guided erector spinae plane catheter for thoracotomy: a case report. Anaesth. pain intensive care 2021;25(6):812–815; \u0000DOI: 10.35975/apic.v25i6.1707 \u0000Received: August 16, 2021, Reviewed: October 28, 2021, Accepted: October 31, 2021","PeriodicalId":7735,"journal":{"name":"Anaesthesia, Pain & Intensive Care","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45288194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incoherency between the clinical condition and the chest X-ray result in COVID-19 patients: a case series 新冠肺炎患者的临床状况与胸部X光检查结果之间的不一致:一个病例系列
IF 0.2 Q4 Medicine Pub Date : 2021-12-12 DOI: 10.35975/apic.v25i6.1710
S. Permana, D. Aditianingsih, Muhammad Husni Thamrin, A. -, P. -
Despite the routine dependence upon chest X–ray (CXR) to monitor COVID-10 patients’ condition, we found that CXR and the clinical condition of some patients were incoherent, especially regarding the need of oxygen supplementation. In our patients, the incoherency was found in three patients, although, the PCR test result was still positive. In the first patient, we noted from the CXR that the pulmonary infiltrate was getting worse, but the oxygen demand was getting less and the PaO2/FiO2 was getting better on Day 4. For the second patient it happened on Day 4 and 5. In our third patient, it happened on the Day 6 and 11. All of the patients were cured and discharged home safely. Our finding indicates that we have to rely more on the clinical condition and subjective complaints of the patients, rather than CXR results to evaluate the therapy because there may be an incoherency between the two. Key word: COVID-19; Timeline; Incoherency; Clinical condition Citation: Permana SA, Aditianingsih D, Thamrin MH, Arifin, Purwoko. Incoherency between the clinical condition and chest X-ray result in COVID-19 patients: a case series. Anaesth. pain intensive care 2021;25(6):798–803 ; DOI: 10.35975/apic.v25i6.1710 Received: September 11, 2021, Reviewed: September 22, 2021, Accepted: September 24, 2021
尽管常规依赖胸部X射线(CXR)来监测COVID-10患者的病情,但我们发现CXR与一些患者的临床病情不一致,尤其是在补充氧气的需求方面。在我们的患者中,在三名患者中发现了不连贯,尽管PCR检测结果仍然呈阳性。在第一例患者中,我们从CXR中注意到,肺部浸润越来越严重,但氧气需求越来越少,第4天的PaO2/FiO2也越来越好。第二名患者发生在第4天和第5天。在我们的第三名患者中,它发生在第6天和第11天。所有的病人都治愈了,并安全出院回家。我们的发现表明,我们必须更多地依赖患者的临床状况和主观抱怨,而不是CXR结果来评估治疗,因为两者之间可能存在不连贯性。关键词:新冠肺炎;时间线;语无伦次;临床状况引文:Permana SA,Aditianingsih D,Thamrin MH,Arifin,Purwoko。新冠肺炎患者的临床状况和胸部X光检查结果不一致:病例系列。Anaesth。疼痛重症监护2021;25(6):798–803;DOI:10.35975/apic.v25i6.1710接收日期:2021年9月11日,审核日期:2021月22日,接受日期:2021
{"title":"Incoherency between the clinical condition and the chest X-ray result in COVID-19 patients: a case series","authors":"S. Permana, D. Aditianingsih, Muhammad Husni Thamrin, A. -, P. -","doi":"10.35975/apic.v25i6.1710","DOIUrl":"https://doi.org/10.35975/apic.v25i6.1710","url":null,"abstract":"Despite the routine dependence upon chest X–ray (CXR) to monitor COVID-10 patients’ condition, we found that CXR and the clinical condition of some patients were incoherent, especially regarding the need of oxygen supplementation. In our patients, the incoherency was found in three patients, although, the PCR test result was still positive. In the first patient, we noted from the CXR that the pulmonary infiltrate was getting worse, but the oxygen demand was getting less and the PaO2/FiO2 was getting better on Day 4. For the second patient it happened on Day 4 and 5. In our third patient, it happened on the Day 6 and 11. All of the patients were cured and discharged home safely. \u0000Our finding indicates that we have to rely more on the clinical condition and subjective complaints of the patients, rather than CXR results to evaluate the therapy because there may be an incoherency between the two. \u0000Key word: COVID-19; Timeline; Incoherency; Clinical condition \u0000Citation: Permana SA, Aditianingsih D, Thamrin MH, Arifin, Purwoko. Incoherency between the clinical condition and chest X-ray result in COVID-19 patients: a case series. Anaesth. pain intensive care 2021;25(6):798–803 ; \u0000DOI: 10.35975/apic.v25i6.1710 \u0000Received: September 11, 2021, Reviewed: September 22, 2021, Accepted: September 24, 2021","PeriodicalId":7735,"journal":{"name":"Anaesthesia, Pain & Intensive Care","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42854503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypopigmentation and subcutaneous fat atrophy associated with corticosteroid injection: a case report 皮质类固醇注射引起的色素沉着减退和皮下脂肪萎缩1例
IF 0.2 Q4 Medicine Pub Date : 2021-12-12 DOI: 10.35975/apic.v25i6.1708
Fata Prihatsari, H. Hidayati, D. Damayanti, Trianggoro Budisulistyo
Corticosteroid injections have been shown to be an effective treatment modality in many of the musculoskeletal and rheumatologic conditions. Yet, the potential adverse effects of corticosteroid injections have not been given much attention. One of the potential adverse effects that should be considered by clinicians is skin hypopigmentation and subcutaneous fat atrophy. Although it is a rare side effect, it may have cosmetically unpleasant effect. The aim of this case report is to highlight the importance of providing adequate information to the patients regarding these dermal adverse effects of corticosteroid injections. We report the case of a 31-year-old female who suffered from skin hypopigmentation and subcutaneous fat atrophy after triamcinolone injection given for de Quervain’s tenosynovitis. Key words: de Quervain’s tenosynovitis; Fat atrophy; Hypopigmentation; Corticosteroid injections; Adverse effects; Pain Citation: Prihatsari F, Hidayati HB, Damayanti D, Budisulistyo T. Hypopigmentation and subcutaneous fat atrophy associated with corticosteroid injection: a case report. Anaesth. pain intensive care 2021;25(6):807–811; DOI: 10.35975/apic.v25i6.1708
皮质类固醇注射已被证明是一种有效的治疗方式在许多肌肉骨骼和风湿病条件。然而,皮质类固醇注射的潜在不良影响尚未得到重视。临床医生应该考虑的潜在不良反应之一是皮肤色素沉着和皮下脂肪萎缩。虽然这是一种罕见的副作用,但它可能会产生不愉快的美容效果。本病例报告的目的是强调向患者提供有关皮质类固醇注射对皮肤不良反应的充分信息的重要性。我们报告一例31岁的女性,在注射曲安奈德治疗de Quervain的腱鞘炎后出现皮肤色素沉着和皮下脂肪萎缩。关键词:德奎尔凡氏腱鞘炎;脂肪萎缩;Hypopigmentation;皮质类固醇注射;不利影响;引用本文:Prihatsari F, Hidayati HB, Damayanti D, Budisulistyo T.皮质类固醇注射相关的色素沉着和皮下脂肪萎缩1例报告。Anaesth。疼痛重症监护2021;25(6):807-811;DOI: 10.35975 / apic.v25i6.1708
{"title":"Hypopigmentation and subcutaneous fat atrophy associated with corticosteroid injection: a case report","authors":"Fata Prihatsari, H. Hidayati, D. Damayanti, Trianggoro Budisulistyo","doi":"10.35975/apic.v25i6.1708","DOIUrl":"https://doi.org/10.35975/apic.v25i6.1708","url":null,"abstract":"Corticosteroid injections have been shown to be an effective treatment modality in many of the musculoskeletal and rheumatologic conditions. Yet, the potential adverse effects of corticosteroid injections have not been given much attention. One of the potential adverse effects that should be considered by clinicians is skin hypopigmentation and subcutaneous fat atrophy. Although it is a rare side effect, it may have cosmetically unpleasant effect. The aim of this case report is to highlight the importance of providing adequate information to the patients regarding these dermal adverse effects of corticosteroid injections. We report the case of a 31-year-old female who suffered from skin hypopigmentation and subcutaneous fat atrophy after triamcinolone injection given for de Quervain’s tenosynovitis. \u0000Key words: de Quervain’s tenosynovitis; Fat atrophy; Hypopigmentation; Corticosteroid injections; Adverse effects; Pain \u0000Citation: Prihatsari F, Hidayati HB, Damayanti D, Budisulistyo T. Hypopigmentation and subcutaneous fat atrophy associated with corticosteroid injection: a case report. Anaesth. pain intensive care 2021;25(6):807–811; \u0000DOI: 10.35975/apic.v25i6.1708","PeriodicalId":7735,"journal":{"name":"Anaesthesia, Pain & Intensive Care","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42135740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Febrile seizure secondary to opioid and benzodiazepine withdrawal in post-operative airway pediatric surgery: a case report 小儿气道手术后阿片类药物和苯二氮卓类药物停药继发发热性癫痫1例报告
IF 0.2 Q4 Medicine Pub Date : 2021-12-12 DOI: 10.35975/apic.v25i6.1709
Muhamad Rafiqi Hehsan, Wan Fadzlina Wan Muhd Shukeri
The sedoanalgesic drugs frequently have to be administered to relieve pain and anxiety of patients in intensive care units (ICU). An ideal agent would be rapidly metabolized, and facilitate desirable level of sedation without compromising hemodynamic and respiratory function. This makes opioids and benzodiazepines to be the most commonly prescribed drugs in intensive care. However, weaning off from these drugs may be associated with withdrawal effects. We present a case report of febrile seizure following airway pediatric surgery and opiate and benzodiazepine discontinuation. The weaning off process from these drugs should be meticulously done especially in pediatric age group to avoid subsequent complications. Key words: Febrile seizure; Opioids; Benzodiazepine; Withdrawal; Post-operative; Airways Abbreviations: PICU - Pediatric intensive care unit; IWS - Iatrogenic withdrawal syndrome Citation: Hehsan MR, Shukeri WFWM. Febrile seizure secondary to opioid and benzodiazepine withdrawal in post-operative airway pediatric surgery: a case report. Anaesth. pain intensive care 2021;25(6):804–806: DOI: 10.35975/apic.v25i6.1709 Received: September 10, 2021, Reviewed: September 18, 2021, Accepted: October 25, 2021
在重症监护室(ICU)中,为了缓解患者的疼痛和焦虑,必须经常服用镇静药。理想的药物可以快速代谢,并在不损害血液动力学和呼吸功能的情况下促进理想的镇静水平。这使得阿片类药物和苯二氮卓类药物成为重症监护中最常见的处方药物。然而,停用这些药物可能会产生戒断效应。我们报告了一例儿童气道手术后的发热性癫痫,停用阿片类药物和苯二氮卓类药物。这些药物的断奶过程应该仔细进行,尤其是在儿科年龄组,以避免随后的并发症。关键词:伤寒;阿片类药物;苯二氮卓类药物;撤回术后;航空缩写:PICU-儿科重症监护室;IWS-医源性戒断综合征引文:Hehsan MR,Shukeri WFWM。小儿气道手术后阿片类药物和苯二氮卓类药物停药继发的发热性癫痫:一例报告。Anaesth。疼痛重症监护2021;25(6):804–806:DOI:10.35975/apic.v25i6.1709接收日期:2021年9月10日,审核日期:2021月18日,接受日期:2020年10月25日
{"title":"Febrile seizure secondary to opioid and benzodiazepine withdrawal in post-operative airway pediatric surgery: a case report","authors":"Muhamad Rafiqi Hehsan, Wan Fadzlina Wan Muhd Shukeri","doi":"10.35975/apic.v25i6.1709","DOIUrl":"https://doi.org/10.35975/apic.v25i6.1709","url":null,"abstract":"The sedoanalgesic drugs frequently have to be administered to relieve pain and anxiety of patients in intensive care units (ICU). An ideal agent would be rapidly metabolized, and facilitate desirable level of sedation without compromising hemodynamic and respiratory function. This makes opioids and benzodiazepines to be the most commonly prescribed drugs in intensive care. However, weaning off from these drugs may be associated with withdrawal effects. We present a case report of febrile seizure following airway pediatric surgery and opiate and benzodiazepine discontinuation. The weaning off process from these drugs should be meticulously done especially in pediatric age group to avoid subsequent complications. \u0000Key words: Febrile seizure; Opioids; Benzodiazepine; Withdrawal; Post-operative; Airways \u0000Abbreviations: PICU - Pediatric intensive care unit; IWS - Iatrogenic withdrawal syndrome \u0000Citation: Hehsan MR, Shukeri WFWM. Febrile seizure secondary to opioid and benzodiazepine withdrawal in post-operative airway pediatric surgery: a case report. Anaesth. pain intensive care 2021;25(6):804–806: \u0000DOI: 10.35975/apic.v25i6.1709 \u0000Received: September 10, 2021, Reviewed: September 18, 2021, Accepted: October 25, 2021","PeriodicalId":7735,"journal":{"name":"Anaesthesia, Pain & Intensive Care","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41378076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparison of recovery time with target controlled infusion of propofol with sevoflurane anesthesia using bispectral index monitoring in vitrectomy surgery 应用双频谱指数监测靶控输注丙泊酚与七氟醚麻醉在玻璃体切除术中恢复时间的比较
IF 0.2 Q4 Medicine Pub Date : 2021-12-01 DOI: 10.35975/apic.v25i6.1689
A. Tantri, R. B. Sukmono, Linda Stefanie Atmadja
Background: Rapid recovery after anesthesia is critical and is associated with the anesthetic agents used. The bispectral index (BIS) monitoring to guide anesthetic agents' doses may play a significant role in the recovery time. This study compared recovery time after Target Controlled Infusion (TCI) of propofol with sevoflurane anesthesia by using BIS monitoring during vitrectomy surgery.  Methodology: This was a prospective observational, randomized study on 40 patients aged 18–65 y, physical status ASA I–II, body mass index (BMI) 18–30 kg/m2, who underwent vitrectomy surgery. Subjects were randomly assigned into two groups, Group P – the TCI propofol group, and Group S – the sevoflurane group. Subjects in the Group P received TCI propofol (Schnider), and subjects in the Group S received sevoflurane for anesthesia maintenance, with a targeted BIS score of 40–60. Inj. fentanyl 1 µg/kg was administered if there was an increase in blood pressure, heart rate and/or BIS that could not be overcome by increasing the dose of TCI propofol or sevoflurane. Recovery time was calculated from when the maintenance regimen was stopped until the patient was able to obey simple commands. Recovery time, fentanyl consumption, postoperative agitation, nausea and vomiting incidence were noted and analyzed with SPSS v21.0 for Windows. T–Test or Mann–Whitney U test was performed to analyze the data.  Result: Recovery time in the Group P [11.5 (5–25) min)] was not significantly different from the Group S [9 (4–18) min, p = 0.139]. Total fentanyl consumption was higher in the Group P than in the Group S (1.765 vs. 1.428 µg/kg). The frequency of agitation during recovery was higher in the Group S than in the Group P (30% vs. 20%) Conclusion: There was no significant difference in recovery time between target controlled infusion of propofol and BIS controlled sevoflurane anesthesia in vitrectomy. Total fentanyl consumption was higher in the Group P than in the sevoflurane group. The impact of these anesthetic regimens on postoperative agitation needs further investigation. Key words: Intravenous anesthesia; Bispectral index monitoring; BIS;  Propofol; Sevoflurane; Target Controlled Infusion; TCI; Vitrectomy Citation: Tantri AR, Sukmono RB, Atmadja LS. Comparison of recovery time with target controlled infusion of propofol with sevoflurane anesthesia using bispectral index monitoring in vitrectomy surgery. Anaesth. pain intensive care 2021;25(6):707–712: DOI: 10.35975/apic.v25i6.1689
背景:麻醉后的快速恢复是至关重要的,并且与所使用的麻醉剂有关。双频谱指数(BIS)监测可以指导麻醉剂的剂量,这可能在恢复时间中发挥重要作用。本研究通过BIS监测比较了玻璃体切除术中靶向控制输注丙泊酚和七氟醚麻醉后的恢复时间。方法:这是一项前瞻性观察性随机研究,对象为40名年龄在18-65岁、身体状况ASA I-II、体重指数(BMI)为18-30 kg/m2的接受玻璃体切除手术的患者。受试者被随机分为两组,P组为TCI丙泊酚组,S组为七氟醚组。P组受试者接受TCI丙泊酚(Schnider),S组受试对象接受七氟醚维持麻醉,目标BIS评分为40-60。Inj。如果血压、心率和/或BIS的增加无法通过增加TCI丙泊酚或七氟醚的剂量来克服,则给予芬太尼1µg/kg。恢复时间从停止维持方案开始计算,直到患者能够服从简单的命令。记录恢复时间、芬太尼用量、术后躁动、恶心呕吐发生率,并用SPSS v21.0 for Windows进行分析。进行T检验或Mann-Whitney U检验来分析数据。结果:P组的恢复时间[11.5(5-25)分钟]与S组[9(4-18)分钟,P=0.139]没有显著差异。P组的芬太尼总消耗量高于S组(1.765 vs.1.428µg/kg)。S组在恢复过程中的搅动频率高于P组(30%对20%)。结论:在玻璃体切除术中,靶控输注丙泊酚和BIS控制七氟醚麻醉在恢复时间上没有显著差异。P组芬太尼总消耗量高于七氟醚组。这些麻醉方案对术后躁动的影响需要进一步研究。关键词:静脉麻醉;双谱指数监测;BIS;异丙酚;七氟醚;靶向控制输液;TCI;玻璃体切除术引文:Tantri AR,Sukmono RB,Atmadja LS。在玻璃体切除术中使用双频谱指数监测与靶控输注丙泊酚和七氟醚麻醉的恢复时间比较。Anaesth。疼痛重症监护2021;25(6):707–712:DOI:10.35975/apic.v25i6.1689
{"title":"Comparison of recovery time with target controlled infusion of propofol with sevoflurane anesthesia using bispectral index monitoring in vitrectomy surgery","authors":"A. Tantri, R. B. Sukmono, Linda Stefanie Atmadja","doi":"10.35975/apic.v25i6.1689","DOIUrl":"https://doi.org/10.35975/apic.v25i6.1689","url":null,"abstract":"Background: Rapid recovery after anesthesia is critical and is associated with the anesthetic agents used. The bispectral index (BIS) monitoring to guide anesthetic agents' doses may play a significant role in the recovery time. This study compared recovery time after Target Controlled Infusion (TCI) of propofol with sevoflurane anesthesia by using BIS monitoring during vitrectomy surgery.  \u0000Methodology: This was a prospective observational, randomized study on 40 patients aged 18–65 y, physical status ASA I–II, body mass index (BMI) 18–30 kg/m2, who underwent vitrectomy surgery. Subjects were randomly assigned into two groups, Group P – the TCI propofol group, and Group S – the sevoflurane group. Subjects in the Group P received TCI propofol (Schnider), and subjects in the Group S received sevoflurane for anesthesia maintenance, with a targeted BIS score of 40–60. Inj. fentanyl 1 µg/kg was administered if there was an increase in blood pressure, heart rate and/or BIS that could not be overcome by increasing the dose of TCI propofol or sevoflurane. Recovery time was calculated from when the maintenance regimen was stopped until the patient was able to obey simple commands. Recovery time, fentanyl consumption, postoperative agitation, nausea and vomiting incidence were noted and analyzed with SPSS v21.0 for Windows. T–Test or Mann–Whitney U test was performed to analyze the data.  \u0000Result: Recovery time in the Group P [11.5 (5–25) min)] was not significantly different from the Group S [9 (4–18) min, p = 0.139]. Total fentanyl consumption was higher in the Group P than in the Group S (1.765 vs. 1.428 µg/kg). The frequency of agitation during recovery was higher in the Group S than in the Group P (30% vs. 20%) \u0000Conclusion: There was no significant difference in recovery time between target controlled infusion of propofol and BIS controlled sevoflurane anesthesia in vitrectomy. Total fentanyl consumption was higher in the Group P than in the sevoflurane group. The impact of these anesthetic regimens on postoperative agitation needs further investigation. \u0000Key words: Intravenous anesthesia; Bispectral index monitoring; BIS;  Propofol; Sevoflurane; Target Controlled Infusion; TCI; Vitrectomy \u0000Citation: Tantri AR, Sukmono RB, Atmadja LS. Comparison of recovery time with target controlled infusion of propofol with sevoflurane anesthesia using bispectral index monitoring in vitrectomy surgery. Anaesth. pain intensive care 2021;25(6):707–712: \u0000DOI: 10.35975/apic.v25i6.1689","PeriodicalId":7735,"journal":{"name":"Anaesthesia, Pain & Intensive Care","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44707946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
INFLUENCE OF IRRATIONAL PRESCRIPTION OF ANTIBACTERIAL THERAPY ON THE PROGNOSIS OF TREATMENT AND SURVIVAL IN PATIENTS WITH COVID-19 抗菌药物处方不合理对COVID-19患者治疗预后及生存的影响
IF 0.2 Q4 Medicine Pub Date : 2021-11-25 DOI: 10.25284/2519-2078.4(97).2021.248405
A. Kotliar, S. Dubrov, S. Sereda, M. Denisyuk, G. Ponyatovska
IIntroduction. The COVID-19 pandemic became a major challenge for healthcare systems around the world. The development and improvement of basic treatments for coronavirus patients is important to improve public health and improve quality of life after recovery.The aim of the study: to determine the frequency and structure of prescribing antibacterial drugs in the prehospital and hospital stages, used in patients with COVID-19. Assess the relationship between irrational use of antibacterial drugs with the length of hospital stay of patients with coronavirus disease, the risk of transfer to the intensive care unit (ICU) and mortality.Materials and methods: Statistical, retrospective analysis of 400 case histories of patients with COVID-19 who were treated at the Municipal Non-Profit Enterprise «Kyiv City Clinical Hospital №17» (KNP «KMKL#17») for the period from September 2020 to November 2021 with severe coronavirus disease.Results: 400 medical charts were selected for the study, which were divided into two groups according to the purpose of antibacterial therapy. Of the group of patients who received pre-hospital antibacterial therapy (200 people), indications for its appointment had only 7 % of patients. Among the group receiving antibacterial drugs there is a prolongation of the length of stay in the hospital, the risk of transfer to ICU increases. There is also higher risk of mortality in patients of group 1 (14,5 %), compared with group 2 (8 %), whose antibacterial drugs were not prescribed at the prehospital stage.Conclusion: as a result of the study it was found that patients who were unreasonably prescribed antibacterial therapy prolongs the period of general hospitalization by 2.3 ± 0.8 days, increasing the need for transfer of patients due to deterioration to ICU by an average of 13 %, increase in the incidence of antibiotic-associated diarrhea by 7-8 %, and there is a tendency to increase mortality from COVID-19. Antibacterial drugs should be used only on the basis of indications in the case of proven bacterial co-infection (superinfection) or reasonable suspicion of it in patients with respiratory disease caused by SARS-CoV-2 and in no case should be prophylactic.
IIntroduction。COVID-19大流行成为世界各地卫生保健系统面临的重大挑战。新冠肺炎患者基础治疗方法的发展和完善,对改善公众健康、提高康复后生活质量具有重要意义。本研究的目的是:确定COVID-19患者院前和住院阶段抗菌药物的使用频率和结构。评估不合理使用抗菌药物与冠状病毒病患者住院时间、转入重症监护病房(ICU)风险和死亡率的关系。材料和方法:对2020年9月至2021年11月期间在市非营利企业“基辅市17号临床医院”(KNP“KMKL#17”)治疗的400例COVID-19患者的病例史进行统计和回顾性分析。结果:选取400张病历进行研究,根据抗菌治疗目的分为两组。在接受院前抗菌治疗的患者组(200人)中,其预约指征仅占7%。在接受抗菌药物治疗的患者中,住院时间延长,转至ICU的风险增加。与院前未开抗菌药物的2组患者(8%)相比,1组患者的死亡率(14.5%)也更高。结论:本研究发现,不合理给予抗菌药物治疗的患者一般住院时间延长2.3±0.8天,恶化患者转至ICU的需要平均增加13%,抗生素相关性腹泻发生率增加7- 8%,COVID-19死亡率有增加的趋势。由SARS-CoV-2引起的呼吸道疾病患者,经证实存在细菌共感染(重复感染)或有合理怀疑时,应根据适应证使用抗菌药物,在任何情况下均不得使用预防性药物。
{"title":"INFLUENCE OF IRRATIONAL PRESCRIPTION OF ANTIBACTERIAL THERAPY ON THE PROGNOSIS OF TREATMENT AND SURVIVAL IN PATIENTS WITH COVID-19","authors":"A. Kotliar, S. Dubrov, S. Sereda, M. Denisyuk, G. Ponyatovska","doi":"10.25284/2519-2078.4(97).2021.248405","DOIUrl":"https://doi.org/10.25284/2519-2078.4(97).2021.248405","url":null,"abstract":"IIntroduction. The COVID-19 pandemic became a major challenge for healthcare systems around the world. The development and improvement of basic treatments for coronavirus patients is important to improve public health and improve quality of life after recovery.\u0000The aim of the study: to determine the frequency and structure of prescribing antibacterial drugs in the prehospital and hospital stages, used in patients with COVID-19. Assess the relationship between irrational use of antibacterial drugs with the length of hospital stay of patients with coronavirus disease, the risk of transfer to the intensive care unit (ICU) and mortality.\u0000Materials and methods: Statistical, retrospective analysis of 400 case histories of patients with COVID-19 who were treated at the Municipal Non-Profit Enterprise «Kyiv City Clinical Hospital №17» (KNP «KMKL#17») for the period from September 2020 to November 2021 with severe coronavirus disease.\u0000Results: 400 medical charts were selected for the study, which were divided into two groups according to the purpose of antibacterial therapy. Of the group of patients who received pre-hospital antibacterial therapy (200 people), indications for its appointment had only 7 % of patients. Among the group receiving antibacterial drugs there is a prolongation of the length of stay in the hospital, the risk of transfer to ICU increases. There is also higher risk of mortality in patients of group 1 (14,5 %), compared with group 2 (8 %), whose antibacterial drugs were not prescribed at the prehospital stage.\u0000Conclusion: as a result of the study it was found that patients who were unreasonably prescribed antibacterial therapy prolongs the period of general hospitalization by 2.3 ± 0.8 days, increasing the need for transfer of patients due to deterioration to ICU by an average of 13 %, increase in the incidence of antibiotic-associated diarrhea by 7-8 %, and there is a tendency to increase mortality from COVID-19. Antibacterial drugs should be used only on the basis of indications in the case of proven bacterial co-infection (superinfection) or reasonable suspicion of it in patients with respiratory disease caused by SARS-CoV-2 and in no case should be prophylactic.","PeriodicalId":7735,"journal":{"name":"Anaesthesia, Pain & Intensive Care","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74937137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
РЕТРОСПЕКТИВНЫЙ АНАЛИЗ ПРИЧИН ЛЕТАЛЬНОСТИ У БОЛЬНЫХ С ТЯЖЕЛЫМ ТЕЧЕНИЕМ COVID-19
IF 0.2 Q4 Medicine Pub Date : 2021-11-25 DOI: 10.25284/2519-2078.4(97).2021.248401
S. Sereda, S. Dubrov, M. Denysiuk, O. Kotliar, S. Cherniaiev, Y. Zaikin, T. Baranovska, O. Havrylenko, V. Borisova, G. Ponyatovska
In Ukraine, more than 3.5 million cases of COVID-19 have been registered during the pandemic, and the death toll is almost 90,000. Ukraine is a leader in Europe in the growth of new cases of COVID-19 and mortality from this disease. The search for effective treatment regimens and new approaches to the management of patients with coronavirus disease in order to reduce the severity of coronavirus disease, reduce mortality, the number of complications and improve the rehabilitation period is very important nowadays.The aim of the work. To determine the main causes of mortality in patients with severe COVID-19 by analyzing the frequency and structure of complications in deceased patients.Materials and methods. The study conducted a retrospective analysis of 122 medical charts of deceased patients with COVID-19 who were hospitalized in a communal non-profit enterprise “Kyiv city clinical hospital №17” for the period from September 2020 to November 2021.Results and discussion. The overall mortality among patients with COVID-19 was 9.3%, in the intensive care unit (ICU) – 48.4%. The most common causes of death in patients with COVID-19 were: respiratory failure (RF) – 100% of cases, pulmonary embolism (PE) and acute heart failure (AHF) - about 60%. The average length of stay of patients in inpatient treatment was 11.67 ± 8.05 days, and in the intensive care unit – 7.94 ± 6.24 days. The mean age of patients hospitalized in the ICU was 63.5 ± 12.9 years and the mean age of patients who died was 71.2 ± 10.29 years.Prognostically significant criteria for lethal consequences were the presence of comorbidity: cardiovascular diseases- 92.3%, endocrine system diseases – 28.4%, nervous system diseases – 23.07%, kidney diseases – 9.6%, cancer – 9,6%, autoimmune conditions – 7.69%, varicose veins – 5.7%, respiratory system diseases – 5.7%.In patients with fatal outcome lymphopenia (84.6%) was observed in patients on admission to the ICU.Vasopressor and inotropic support was performed in 50 % of patients with COVID-19. In 25 % of those who died during long-term treatment and long-term respiratory support, there was the development of multiple organ failure, which in most cases was the point of no return.Conclusions. The most common causes of death were: respiratory failure, thrombosis, acute cardiovascular failure, sepsis and multiple organ failure. The main nature of the complications is common, but the cohort may be affected by different factors and the percentage of complications may differ in other hospitals.
在乌克兰,疫情期间登记的COVID-19病例超过350万例,死亡人数接近9万人。在新发COVID-19病例和死亡率增长方面,乌克兰在欧洲处于领先地位。寻找有效的治疗方案和治疗新方法,以降低冠状病毒病的严重程度,降低死亡率,减少并发症的发生,延长康复期,是当前研究的重要内容。工作的目的。通过分析死亡患者并发症的发生频率和结构,确定重症COVID-19患者死亡的主要原因。材料和方法。该研究对2020年9月至2021年11月期间在社区非营利企业“基辅市第17临床医院”住院的122例COVID-19死亡患者的病历进行了回顾性分析。结果和讨论。COVID-19患者的总死亡率为9.3%,重症监护病房(ICU)的总死亡率为48.4%。COVID-19患者最常见的死亡原因是:呼吸衰竭(RF) - 100%的病例,肺栓塞(PE)和急性心力衰竭(AHF) -约60%。住院患者平均住院时间为11.67±8.05 d,重症监护病房平均住院时间为- 7.94±6.24 d。ICU住院患者平均年龄为63.5±12.9岁,死亡患者平均年龄为71.2±10.29岁。致命后果的预后显著标准是存在合并症:心血管疾病- 92.3%,内分泌系统疾病- 28.4%,神经系统疾病- 23.07%,肾脏疾病- 9.6%,癌症- 9.6%,自身免疫性疾病- 7.69%,静脉曲张- 5.7%,呼吸系统疾病- 5.7%。在重症监护室(ICU)入院患者中,出现了致死性淋巴细胞减少(84.6%)。50%的COVID-19患者接受了血管加压剂和肌力支持。在长期治疗和长期呼吸支持期间死亡的患者中,有25%的患者出现了多器官功能衰竭,这在大多数情况下是无法挽回的。最常见的死亡原因是:呼吸衰竭、血栓形成、急性心血管衰竭、败血症和多器官衰竭。并发症的主要性质是共同的,但队列可能受到不同因素的影响,并发症的百分比可能在其他医院有所不同。
{"title":"РЕТРОСПЕКТИВНЫЙ АНАЛИЗ ПРИЧИН ЛЕТАЛЬНОСТИ У БОЛЬНЫХ С ТЯЖЕЛЫМ ТЕЧЕНИЕМ COVID-19","authors":"S. Sereda, S. Dubrov, M. Denysiuk, O. Kotliar, S. Cherniaiev, Y. Zaikin, T. Baranovska, O. Havrylenko, V. Borisova, G. Ponyatovska","doi":"10.25284/2519-2078.4(97).2021.248401","DOIUrl":"https://doi.org/10.25284/2519-2078.4(97).2021.248401","url":null,"abstract":"In Ukraine, more than 3.5 million cases of COVID-19 have been registered during the pandemic, and the death toll is almost 90,000. Ukraine is a leader in Europe in the growth of new cases of COVID-19 and mortality from this disease. The search for effective treatment regimens and new approaches to the management of patients with coronavirus disease in order to reduce the severity of coronavirus disease, reduce mortality, the number of complications and improve the rehabilitation period is very important nowadays.\u0000The aim of the work. To determine the main causes of mortality in patients with severe COVID-19 by analyzing the frequency and structure of complications in deceased patients.\u0000Materials and methods. The study conducted a retrospective analysis of 122 medical charts of deceased patients with COVID-19 who were hospitalized in a communal non-profit enterprise “Kyiv city clinical hospital №17” for the period from September 2020 to November 2021.\u0000Results and discussion. The overall mortality among patients with COVID-19 was 9.3%, in the intensive care unit (ICU) – 48.4%. The most common causes of death in patients with COVID-19 were: respiratory failure (RF) – 100% of cases, pulmonary embolism (PE) and acute heart failure (AHF) - about 60%. The average length of stay of patients in inpatient treatment was 11.67 ± 8.05 days, and in the intensive care unit – 7.94 ± 6.24 days. The mean age of patients hospitalized in the ICU was 63.5 ± 12.9 years and the mean age of patients who died was 71.2 ± 10.29 years.\u0000Prognostically significant criteria for lethal consequences were the presence of comorbidity: cardiovascular diseases- 92.3%, endocrine system diseases – 28.4%, nervous system diseases – 23.07%, kidney diseases – 9.6%, cancer – 9,6%, autoimmune conditions – 7.69%, varicose veins – 5.7%, respiratory system diseases – 5.7%.\u0000In patients with fatal outcome lymphopenia (84.6%) was observed in patients on admission to the ICU.\u0000Vasopressor and inotropic support was performed in 50 % of patients with COVID-19. In 25 % of those who died during long-term treatment and long-term respiratory support, there was the development of multiple organ failure, which in most cases was the point of no return.\u0000Conclusions. The most common causes of death were: respiratory failure, thrombosis, acute cardiovascular failure, sepsis and multiple organ failure. The main nature of the complications is common, but the cohort may be affected by different factors and the percentage of complications may differ in other hospitals.","PeriodicalId":7735,"journal":{"name":"Anaesthesia, Pain & Intensive Care","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76711847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
PRIMARY HYPERPARATHYROIDISM: OPTIMIZATION OF ANAESTHESIA 原发性甲状旁腺功能亢进:麻醉的优化
IF 0.2 Q4 Medicine Pub Date : 2021-11-25 DOI: 10.25284/2519-2078.4(97).2021.248397
S. Tarasenko, S. Dubrov, V. Palamarchuk, M. Gorobeiko, V. Voitenko, O. Yefimova, O. Nechay, P. O. Lishchynsky, V. Smolyar, O. Tovkay, V. L. Rudenko
Background and Aims. The majority of cases of primary hyperparathyreosis (PHPT) due to solitary adenoma and require the target surgery. Research of new anesthesia/analgesia methods, which afford to have an opioid-sparing effect, is going. Methods. 127 patients with PHPT were divided into 3 groups: the group STI-BCSPB (n=26) was used combined general anesthesia (GA) with sevoflurane (SEV), the tracheal intubation (TI) with the myorelaxant introduction and bilateral cervical superficial plexus blockade (BCSPB); the group STI (n=82) was used SEV anaesthesia with IT and no BCSPB; the group PLM-BCSPB (n=19) was provided propofol (P) GA with protection air-ways by laryngeal mask (LM) and BCSPB. In both groups (STI-BCSPB and PLM-BCSPB) were used co-analgesics, such as dexamethasone (DXM) 8 mg IV, 2% lidocaine (L) 1,0-1,5 mg/kg IV, metamizole (M) or paracetamol (P) 1 g IV, dexketoprofen (DKTP) 50 mg IV as pre-emptive analgesia 30 min before surgery. Ketamine 25 mg IV was used for induction anaesthesia in these groups. In STI group only opioid with P were used for induction of GA. Duration of surgery (DoS), anaesthesia (DoA), opioid consumption, time from the operation ending until the eyes opening (EyOp), desaturation was measured. All data M±mResults. DoS for STI-BCSPB, STI and PLM-BCSPB was respectively 38.7±2.7, 37.8±1.3 and 35.6±1.7 min (NS), DoA was respectively 63.8±3.1, 59.4±1.4 m and 53,8±2.7 min (p= 0.028 STI vs PLM-BCSPB, p= 0.024 STI-BCSPB vs PLM-BCSPB, the difference is significant (DS). EyOp was 15.4±1.1, 15.6±1.2 and 11.6±0.9 min respectively for STI-BCSPB, STI and PLM-BCSPB (p=0.022 STI vs PLM-BCSPB (DS) and p=0.025 STI-BCSPB vs PLM-BCSPB (DS). Desaturation (SpO2 below 92%) due to residual sedation and the effect of muscles relaxants was observed in 39 (47.6%) and 11 (42,3%) patients in STI and STI-BCSPB during the first 30 min postop compared to 2 cases (10.5%) in PLM-BCSPB (both STI groups were DS vs PLM-BCSPB, chi-square test). The dose of intra-op fentanyl was 334.3±17.1, 256.5±16.9 197.3±15.3 mcg in STI, STI-BCSPB and PLM-BCSPB respectively, (DS for PLM-BCSPB vs other groups, DS between STI groups).Conclusions. Combine methods GA with BCSPB have some benefits over mono GA. Co-analgesics afford to achieve an opioidsparing effect. Under ectomy of single parathyroid adenoma, the use of propofol and BSCPB with the laryngeal mask without muscles relaxants seems more preferable compared to sevoflurane anesthesia with BBSCP and tracheal intubation due to the shorter anesthesia duration, time to eye-opening after surgery, lower desaturation frequency.
背景和目的。原发性甲状旁腺亢(PHPT)多数因单发性腺瘤而需要手术治疗。新的麻醉/镇痛方法的研究,负担得起阿片类药物的节省作用,正在进行中。方法:127例PHPT患者分为3组:采用全身麻醉(GA)联合七氟醚(SEV)、气管插管(TI)联合肌松剂引入及双侧颈浅丛阻滞(BCSPB)的stii -BCSPB组(n=26);STI组(n=82)采用SEV麻醉合并IT,不使用BCSPB;PLM-BCSPB组(n=19)给予异丙酚(P) GA,喉罩(LM)和BCSPB保护气道。两组(stim - bcspb组和PLM-BCSPB组)均采用地塞米松(DXM) 8 mg IV, 2%利多卡因(L) 1、0 ~ 1、5 mg/kg IV,安咪唑(M)或扑热息痛(P) 1 g IV,右酮洛芬(DKTP) 50 mg IV作为术前30 min的先发制人镇痛。两组均采用氯胺酮25 mg IV进行诱导麻醉。STI组仅用阿片类药物P诱导GA。测量手术持续时间(DoS)、麻醉时间(DoA)、阿片类药物用量、手术结束至睁眼时间(EyOp)、去血饱和度。所有数据M±M。STI- bcspb、STI和PLM-BCSPB的DoS分别为38.7±2.7、37.8±1.3和35.6±1.7 min (NS), DoA分别为63.8±3.1、59.4±1.4 m和53,8±2.7 min (p= 0.028 STI与PLM-BCSPB, p= 0.024 STI- bcspb与PLM-BCSPB,差异有统计学意义(DS)。STI- bcspb、STI和PLM-BCSPB的EyOp分别为15.4±1.1、15.6±1.2和11.6±0.9 min (p=0.022 STI vs PLM-BCSPB (DS), p=0.025 STI- bcspb vs PLM-BCSPB (DS))。STI组和STI- bcspb组分别有39例(47.6%)和11例(42.3%)患者在停药后30分钟内出现残留镇静和肌肉松弛剂作用导致的去饱和(SpO2低于92%),而PLM-BCSPB组只有2例(10.5%)(两组均为DS vs PLM-BCSPB,卡方检验)。芬太尼在STI、STI- bcspb和PLM-BCSPB组的用药剂量分别为334.3±17.1、256.5±16.9、197.3±15.3 mcg (PLM-BCSPB组与其他组的DS、STI组间的DS)。结合BCSPB遗传算法与单遗传算法相比,具有一定的优势。协同镇痛药可达到阿片节约的效果。在单发甲状旁腺瘤切除术中,由于麻醉时间短、术后睁眼时间短、去饱和频率低,异丙酚和BSCPB联合喉罩不使用肌肉松弛剂比七氟醚联合BBSCP和气管插管更可取。
{"title":"PRIMARY HYPERPARATHYROIDISM: OPTIMIZATION OF ANAESTHESIA","authors":"S. Tarasenko, S. Dubrov, V. Palamarchuk, M. Gorobeiko, V. Voitenko, O. Yefimova, O. Nechay, P. O. Lishchynsky, V. Smolyar, O. Tovkay, V. L. Rudenko","doi":"10.25284/2519-2078.4(97).2021.248397","DOIUrl":"https://doi.org/10.25284/2519-2078.4(97).2021.248397","url":null,"abstract":"Background and Aims. The majority of cases of primary hyperparathyreosis (PHPT) due to solitary adenoma and require the target surgery. Research of new anesthesia/analgesia methods, which afford to have an opioid-sparing effect, is going. Methods. 127 patients with PHPT were divided into 3 groups: the group STI-BCSPB (n=26) was used combined general anesthesia (GA) with sevoflurane (SEV), the tracheal intubation (TI) with the myorelaxant introduction and bilateral cervical superficial plexus blockade (BCSPB); the group STI (n=82) was used SEV anaesthesia with IT and no BCSPB; the group PLM-BCSPB (n=19) was provided propofol (P) GA with protection air-ways by laryngeal mask (LM) and BCSPB. In both groups (STI-BCSPB and PLM-BCSPB) were used co-analgesics, such as dexamethasone (DXM) 8 mg IV, 2% lidocaine (L) 1,0-1,5 mg/kg IV, metamizole (M) or paracetamol (P) 1 g IV, dexketoprofen (DKTP) 50 mg IV as pre-emptive analgesia 30 min before surgery. Ketamine 25 mg IV was used for induction anaesthesia in these groups. In STI group only opioid with P were used for induction of GA. Duration of surgery (DoS), anaesthesia (DoA), opioid consumption, time from the operation ending until the eyes opening (EyOp), desaturation was measured. All data M±m\u0000Results. DoS for STI-BCSPB, STI and PLM-BCSPB was respectively 38.7±2.7, 37.8±1.3 and 35.6±1.7 min (NS), DoA was respectively 63.8±3.1, 59.4±1.4 m and 53,8±2.7 min (p= 0.028 STI vs PLM-BCSPB, p= 0.024 STI-BCSPB vs PLM-BCSPB, the difference is significant (DS). EyOp was 15.4±1.1, 15.6±1.2 and 11.6±0.9 min respectively for STI-BCSPB, STI and PLM-BCSPB (p=0.022 STI vs PLM-BCSPB (DS) and p=0.025 STI-BCSPB vs PLM-BCSPB (DS). Desaturation (SpO2 below 92%) due to residual sedation and the effect of muscles relaxants was observed in 39 (47.6%) and 11 (42,3%) patients in STI and STI-BCSPB during the first 30 min postop compared to 2 cases (10.5%) in PLM-BCSPB (both STI groups were DS vs PLM-BCSPB, chi-square test). The dose of intra-op fentanyl was 334.3±17.1, 256.5±16.9 197.3±15.3 mcg in STI, STI-BCSPB and PLM-BCSPB respectively, (DS for PLM-BCSPB vs other groups, DS between STI groups).\u0000Conclusions. Combine methods GA with BCSPB have some benefits over mono GA. Co-analgesics afford to achieve an opioidsparing effect. Under ectomy of single parathyroid adenoma, the use of propofol and BSCPB with the laryngeal mask without muscles relaxants seems more preferable compared to sevoflurane anesthesia with BBSCP and tracheal intubation due to the shorter anesthesia duration, time to eye-opening after surgery, lower desaturation frequency.","PeriodicalId":7735,"journal":{"name":"Anaesthesia, Pain & Intensive Care","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80821166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TO CHARACTERISTICS OF THE ETIOLOGICAL STRUCTURE AND ANTIBIOTIC SENSITIVITY PATHOGENSOF INFECTIOUS RESPIRATORY ORGANS IN NEWBORN AFTER ARTIFICIAL PULMONARY VENTILATION 新生儿人工肺通气后感染性呼吸器官的病原学结构及抗生素敏感性特点
IF 0.2 Q4 Medicine Pub Date : 2021-11-25 DOI: 10.25284/2519-2078.4(97).2021.248394
B. Levchenko, D. V. Dmitriev, K. Bertsun, N. A. Bagnyuk, O. Nazarchuk
Objective. The study of the etiological structure, properties of pathogens of the Vinnytsia National Medical University named after E. Pirogova, respiratory process in newborns who have underwent artificial mechanical lung ventilation (MLV) and their resistance to antibacterial agents is especially relevant in modern conditions, expands the search for new approaches to pathogens, improves treatment and reduces mortality from this pathology.The purpose of the study - to determine the etiological structure, sensitivity to antibiotics of the leading pathogens of the infectious process of the respiratory system in newborns who were on mechanical ventilation.Materials and methods. In total, the species composition of the leading microorganisms that colonized the airways of 180 newborns treated in the Neonatal Intensive Care Unit (VAITN) of Vinnytsia Regional Children’s Clinical Hospital (VRCCH) was studied in 2020. A total of 285 isolates of microorganisms were isolated. 62 patients who underwent mechanical ventilation were involved in a prospective microbiological study, 86 clinical strains of microorganisms were isolated. The susceptibility of microorganisms to 30 antibacterial agents was determined according to the generally accepted method (order of the Ministry of Health of Ukraine №167; recommendations). Research results. The etiological significance of opportunistic pathogens (Enterobacter cloacae - 29%, Staphylococcus aureus - 24.4%, Pseudomonas aeruginosa - 18.6%, Candida albicans) was proved in patients who were on mechanical ventilation in VAITN VRCCH in 2020 for pneumonia. Clinical strains of S. aureus are sensitive to vancomycin, oxacillin and clindamycin. Conclusions. Pathogens of the respiratory process in newborns who have been on mechanical ventilation, are resistant to a number of antibiotic drugs (cefepime, gentamicin amikacin, piperacillin).
目标。以E. Pirogova命名的Vinnytsia国立医科大学的病原学结构,病原体特性,接受人工机械肺通气(MLV)的新生儿的呼吸过程及其对抗菌药物的耐药性的研究在现代条件下尤其相关,扩大了对病原体新方法的探索,改善了治疗并降低了这种病理的死亡率。目的:探讨机械通气新生儿呼吸系统感染过程中主要病原菌的病原学结构及对抗生素的敏感性。材料和方法。总的来说,我们研究了2020年在Vinnytsia地区儿童临床医院(VRCCH)新生儿重症监护病房(VAITN)治疗的180名新生儿气道上定菌的主要微生物的种类组成。共分离到285株微生物。对62例机械通气患者进行前瞻性微生物学研究,分离出86株临床微生物菌株。微生物对30种抗菌剂的敏感性根据普遍接受的方法(乌克兰卫生部第167号命令;建议)。研究的结果。2020年在VAITN VRCCH进行机械通气的肺炎患者中,条件致病菌(阴沟肠杆菌- 29%,金黄色葡萄球菌- 24.4%,铜绿假单胞菌- 18.6%,白色念珠菌)的病原学意义得到证实。金黄色葡萄球菌临床菌株对万古霉素、恶西林和克林霉素敏感。结论。使用机械通气的新生儿的呼吸过程病原体对许多抗生素药物(头孢吡肟、庆大霉素、阿米卡星、哌拉西林)具有耐药性。
{"title":"TO CHARACTERISTICS OF THE ETIOLOGICAL STRUCTURE AND ANTIBIOTIC SENSITIVITY PATHOGENSOF INFECTIOUS RESPIRATORY ORGANS IN NEWBORN AFTER ARTIFICIAL PULMONARY VENTILATION","authors":"B. Levchenko, D. V. Dmitriev, K. Bertsun, N. A. Bagnyuk, O. Nazarchuk","doi":"10.25284/2519-2078.4(97).2021.248394","DOIUrl":"https://doi.org/10.25284/2519-2078.4(97).2021.248394","url":null,"abstract":"Objective. The study of the etiological structure, properties of pathogens of the Vinnytsia National Medical University named after E. Pirogova, respiratory process in newborns who have underwent artificial mechanical lung ventilation (MLV) and their resistance to antibacterial agents is especially relevant in modern conditions, expands the search for new approaches to pathogens, improves treatment and reduces mortality from this pathology.\u0000The purpose of the study - to determine the etiological structure, sensitivity to antibiotics of the leading pathogens of the infectious process of the respiratory system in newborns who were on mechanical ventilation.\u0000Materials and methods. In total, the species composition of the leading microorganisms that colonized the airways of 180 newborns treated in the Neonatal Intensive Care Unit (VAITN) of Vinnytsia Regional Children’s Clinical Hospital (VRCCH) was studied in 2020. A total of 285 isolates of microorganisms were isolated. 62 patients who underwent mechanical ventilation were involved in a prospective microbiological study, 86 clinical strains of microorganisms were isolated. The susceptibility of microorganisms to 30 antibacterial agents was determined according to the generally accepted method (order of the Ministry of Health of Ukraine №167; recommendations). Research results. The etiological significance of opportunistic pathogens (Enterobacter cloacae - 29%, Staphylococcus aureus - 24.4%, Pseudomonas aeruginosa - 18.6%, Candida albicans) was proved in patients who were on mechanical ventilation in VAITN VRCCH in 2020 for pneumonia. Clinical strains of S. aureus are sensitive to vancomycin, oxacillin and clindamycin.\u0000 Conclusions. Pathogens of the respiratory process in newborns who have been on mechanical ventilation, are resistant to a number of antibiotic drugs (cefepime, gentamicin amikacin, piperacillin).","PeriodicalId":7735,"journal":{"name":"Anaesthesia, Pain & Intensive Care","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77773579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SEVERE COVID-19 IN PATIENT AT EARLY POSTOPERATIVE PERIOD AFTER WHIPPLE’S OPERATION WITH MARGINAL PORTAL VEIN RESECTION whipple手术门静脉边缘切除术后早期重症COVID-19患者
IF 0.2 Q4 Medicine Pub Date : 2021-11-25 DOI: 10.25284/2519-2078.4(97).2021.248407
V. Kopchak, A. Mazur, L. Pererva, О. Khomenko, L. Maksymenko, R. Zatsarynnyy, P. Azadov
Introduction. Pancreatoduodenectomy (PDR or Whipple’s operation) remains the only effective radical method of surgery for tumors of the pancreatic head, distal common bile duct and Vater’s papilla. The most frequent complications of the early postoperative period are: gastrostasis, pancreatic fistula, postoperative bleeding and pulmonary complications. According to World Health Organization (WHO) and reviews, severe COVID-19 usually occurs in older age patients, and in patients with oncological diseases.Case description. Patient V., 64 years old, due to a tumor of the head of the pancreas with invasion of the distal common bile duct and the development of obstructive jaundice, underwent PDR. Histopathologically, ductal adenocarcinoma of the pancreatic head, G-2, was confirmed. The PDR operation was performed within healthy tissues, which was confirmed by histopathology.On the second day after surgery, patient was admitted to ICU because of respiratory failure, the SARS-CoV-2 antigen test was positive, we suggest that the patient was in the latent period of COVID-19 disease during the surgery. Patient received hormone therapy, anticoagulants in therapeutic doses, O2-therapy. On the 5th day, because of severe ARDS, the patient was intubated, on the 7th day - convalescent plasma transfused (1 dose). On the 9th day, a tracheostomy was applied for airways care and early activation. Respiratory support was provided twelve days. Patient received early activation, exercises, as well as early enteral nutrition. After ICU discharge, patient’s condition was complicated by the gastro-intestinal bleeding, blood transfusion and embolization of the dorsal pancreatic artery were performed. On the day 66th after surgery patient was discharged home in satisfactory condition.Conclusion. General care and early activation of the patient within early tracheostomy, convalescent plasma usage and the well-coordinated work of the surgical and anesthesiological teams allows timely identification and elimination of early postoperative complications after Whipple’s operation with marginal resection of the portal vein.
介绍。胰十二指肠切除术(PDR或Whipple手术)仍然是治疗胰头、胆总管远端和沃特乳头肿瘤唯一有效的根治性手术方法。术后早期最常见的并发症有:胃淤积、胰瘘、术后出血和肺部并发症。根据世界卫生组织(世卫组织)和综述,严重的COVID-19通常发生在老年患者和肿瘤疾病患者中。案例描述。患者V., 64岁,因胰头肿瘤侵犯胆总管远端,并发梗阻性黄疸,行PDR。组织病理学证实为胰头导管腺癌,G-2。PDR手术在健康组织内进行,经组织病理学证实。术后第2天患者因呼吸衰竭入住ICU,术中SARS-CoV-2抗原检测阳性,提示术中患者处于COVID-19潜伏期。患者接受激素治疗,治疗剂量的抗凝血剂,o2治疗。第5天,患者因严重ARDS气管插管,第7天恢复期血浆输注(1剂)。第9天行气管切开术进行气道护理和早期激活。给予12天的呼吸支持。患者接受早期激活、锻炼和早期肠内营养。出院后患者并发胃肠道出血,行输血及胰背动脉栓塞术。术后第66天患者出院,出院情况满意。早期气管切开术患者的一般护理和早期激活,恢复期血浆的使用以及手术和麻醉团队的良好协调工作,可以及时发现和消除惠普尔门静脉边缘切除术后早期并发症。
{"title":"SEVERE COVID-19 IN PATIENT AT EARLY POSTOPERATIVE PERIOD AFTER WHIPPLE’S OPERATION WITH MARGINAL PORTAL VEIN RESECTION","authors":"V. Kopchak, A. Mazur, L. Pererva, О. Khomenko, L. Maksymenko, R. Zatsarynnyy, P. Azadov","doi":"10.25284/2519-2078.4(97).2021.248407","DOIUrl":"https://doi.org/10.25284/2519-2078.4(97).2021.248407","url":null,"abstract":"Introduction. Pancreatoduodenectomy (PDR or Whipple’s operation) remains the only effective radical method of surgery for tumors of the pancreatic head, distal common bile duct and Vater’s papilla. The most frequent complications of the early postoperative period are: gastrostasis, pancreatic fistula, postoperative bleeding and pulmonary complications. According to World Health Organization (WHO) and reviews, severe COVID-19 usually occurs in older age patients, and in patients with oncological diseases.\u0000Case description. Patient V., 64 years old, due to a tumor of the head of the pancreas with invasion of the distal common bile duct and the development of obstructive jaundice, underwent PDR. Histopathologically, ductal adenocarcinoma of the pancreatic head, G-2, was confirmed. The PDR operation was performed within healthy tissues, which was confirmed by histopathology.\u0000On the second day after surgery, patient was admitted to ICU because of respiratory failure, the SARS-CoV-2 antigen test was positive, we suggest that the patient was in the latent period of COVID-19 disease during the surgery. Patient received hormone therapy, anticoagulants in therapeutic doses, O2-therapy. On the 5th day, because of severe ARDS, the patient was intubated, on the 7th day - convalescent plasma transfused (1 dose). On the 9th day, a tracheostomy was applied for airways care and early activation. Respiratory support was provided twelve days. Patient received early activation, exercises, as well as early enteral nutrition. After ICU discharge, patient’s condition was complicated by the gastro-intestinal bleeding, blood transfusion and embolization of the dorsal pancreatic artery were performed. On the day 66th after surgery patient was discharged home in satisfactory condition.\u0000Conclusion. General care and early activation of the patient within early tracheostomy, convalescent plasma usage and the well-coordinated work of the surgical and anesthesiological teams allows timely identification and elimination of early postoperative complications after Whipple’s operation with marginal resection of the portal vein.","PeriodicalId":7735,"journal":{"name":"Anaesthesia, Pain & Intensive Care","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91211401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Anaesthesia, Pain & Intensive Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1